A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. (NCT07003984)
A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled, Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children 1 to <12 Years of Age
🩺 Plain-English Summary (8th-Grade Level)
The goal of this multi-center, randomized, double-blind, placebo-controlled study is to evaluate the safety and immunogenicity of CHIKV VLP Vaccine in children 1 to \<12 years of age.
Who can join: Review the eligibility criteria below.
Location: ARK Clinical Research, LLC — Fountain Valley, California
Age range: 1 Year to 11 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (15 Sites)
- ARK Clinical Research, LLC — Fountain Valley, California
- Emerson Clinical Research Institute- DC — Washington D.C., District of Columbia
- Acevedo Clinical Research — Miami, Florida
- Hope Research Network — Miami, Florida
- Velocity Clinical Research-Omaha — Omaha, Nebraska
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
- KidCare Pediatrics — Beaumont, Texas
- Velocity Clinical Research - Salt Lake City — West Jordan, Utah
- CARE CT Group Inc. — Dasmariñas, Cavite
- HIMC Research and Development on Medical Sciences — Imus, Cavite
- Silang Specialist Medical Center — Silang, Cavite
- University of Perpetual Help DALTA Medical Center, Biomedical Research Institute — Las Piñas, National Capital Region
- Institute of Child Health and Human Development, University of the Philippines — Manila, National Capital Region
- University of the Philippines-Philippine General Hospital — Manila,
- CMRC Headlands LLC — San Juan, Puerto Rico
📞 Contact the Study Coordinator
Phone: (844) 422-8274
Email: info@bavarian-nordic.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Chikungunya Virus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.